NAC treatment for repetitive behaviors in Cornelia de Lange syndrome
Treatments studied
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study tests whether N-acetylcysteine (a supplement) can reduce repetitive or self-injurious behaviors in people with Cornelia de Lange syndrome. It involves 4 hospital visits over 18 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 13 and 35 years old.
- You must have a confirmed diagnosis of Cornelia de Lange syndrome.
- You must have significant repetitive or self-injurious behaviors.
- You must be able to attend 4 study visits at Johns Hopkins Hospital over 18 weeks.
- You must not be allergic to N-acetylcysteine or quinine.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a structured behavior assessment and treatment program for children with Cornelia de Lange syndrome who have challenging behaviors. It may help reduce self-injury, aggression, and disruptive behavior through a plan families can carry out.
This trial tests whether lithium can help people with Cornelia de Lange syndrome (CdLS) who have a confirmed NIPBL gene mutation. It might improve their daily life and overall well-being.
This study tests an oral supplement called N-acetylglucosamine (a natural sugar) to see if it can help control Crohn's disease. It involves taking the supplement and attending follow-up visits, including some genetic testing.
This trial tests a potential treatment for people with CACNA1A disorders, which can cause movement problems, migraine, or seizures. The medication may help improve balance and coordination.
This study tests whether N-acetyl cysteine (a supplement-like medicine) changes body and brain function in people with multiple sclerosis. It may help researchers understand how it affects brain chemistry and activity using special brain imaging.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
Hear when a new Cornelia de Lange Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.